Useful links about Reimbursement and access (Netherlands)

Reimbursement and patient access are critical to ensuring that new therapies are both available and financially sustainable. Health authorities evaluate a drug’s clinical benefit and cost-effectiveness to determine pricing and coverage decisions. However, challenges such as complex pricing negotiations, varying health system policies, and equity in access can impact the timely availability of innovative treatments.

Useful links

Organisaties

  • On behalf of the government, National Health Care Institute (Zorginstituut Nederland) works to ensure that everyone in the Netherlands has access to good care, now and in the future: Zorginstituut Nederland
    Check out these 3 documents created by Zorginstituut Nederland (in Dutch) that can help manufacturers get the right information more quickly:
  1. This core document is a tool for submitting a proper and complete reimbursement file.
  2. A checklist that helps the manufacturer provide a complete dossier. This lists which documents are necessary for assessment.
  3. A feedback form, which the Zorginstituut uses to provide feedback on the core document in a personal meeting with the manufacturer.
  • Zorgverzekeraars Nederland (ZN)
  • Health Technology Assessment International is a collaboration of HTA professionals who are dedicated to shaping the future of health systems and improving health outcomes for all people.

Podcast

Interesting podcast series about reimbursement and implementation in the clinical practice: De Bruggenbouwers | Podcast on Spotify (in Dutch)

The Dutch minister of health recently published an overview of patient access programs in Netherlands.